Earnings Per Share, Basic of Y-mAbs Therapeutics, Inc. from 31 Dec 2019 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Y-mAbs Therapeutics, Inc. quarterly and annual Earnings Per Share, Basic in USD/shares history and change rate from 31 Dec 2019 to 30 Jun 2025.
  • Y-mAbs Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending 30 Jun 2025 was -0.07, a 67% increase year-over-year.
  • Y-mAbs Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending 30 Jun 2025 was 0, a 11% increase year-over-year.
  • Y-mAbs Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was -0.67, a 37% decline from 2023.
  • Y-mAbs Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -0.49, a 78% increase from 2022.
  • Y-mAbs Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -2.19, a 71% decline from 2021.
Source SEC data
View on sec.gov
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

Y-mAbs Therapeutics, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 0 -0.07 +0.14 +67% 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 0 -0.12 +0.03 +20% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 0 -0.15 -0.13 -650% 01 Oct 2024 31 Dec 2024 10-K 04 Mar 2025 2024 FY
Q3 2024 0 -0.16 +0.02 +11% 01 Jul 2024 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 0 -0.21 -0.07 -50% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025 2025 Q2
Q1 2024 0 -0.15 0 0% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 0 -0.02 -0.04 -200% 01 Oct 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q3 2023 0 -0.18 +0.45 +71% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024 2024 Q3
Q2 2023 0 -0.14 +0.8 +85% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024 2024 Q2
Q1 2023 -1 -0.15 +0.49 +77% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 -2 0.02 +0.91 01 Oct 2022 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 -3 -0.63 +0.03 +4.5% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 -3 -0.94 -0.41 -77% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 -2 -0.64 -1.44 -180% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q1
Q4 2021 -1 -0.89 -0.41 -85% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 0 -0.66 +0.16 +20% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022 2022 Q3
Q2 2021 -1 -0.53 +0.48 +48% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022 2021 Q3
Q1 2021 -1 0.8 +1.46 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q4 2020 -2 -0.48 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 -0.82 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2021 Q3
Q2 2020 -1.01 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021 2021 Q2
Q1 2020 -0.66 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1

Y-mAbs Therapeutics, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 -0.67 -0.18 -37% 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2025 2024 FY
2023 -0.49 +1.7 +78% 01 Jan 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
2022 -2.19 -0.91 -71% 01 Jan 2022 31 Dec 2022 10-K 29 Feb 2024 2023 FY
2021 -1.28 +1.69 +57% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 -2.97 -0.67 -29% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2022 2021 FY
2019 -2.3 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.